Miss Myrthe Van Der Heide
Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
The impact of comorbidities and substance use on heart failure events and major ventricular arrhythmias in phospholamban p.(Arg14del) positive individuals.
Event: EHRA 2024
Topic: Genetic Aspects of Arrhythmias
Session: Poster session on ventricular tachycardia, others
New joint model for the dynamic prediction of heart failure in phospholamban (PLN) p.(Arg14del) positive individuals
Event: EHRA 2024
Topic: Clinical
Session: Clinical: prevention
The phospholamban (PLN) p.Arg14del risk model; Longitudinal validation and reevaluation of predictors regarding sudden cardiac death (SCD)
Event: EHRA 2023
Topic: Device Treatment
Session: ePoster session 2
Longitudinal validation of the phospholamban (PLN) p.Arg14del risk model
Event: ESC Congress 2022
Topic: Ion Channel Disorders
Session: Emerging role of genetic testing for ventricular arrhythmia management
